Leprosy cost-effectiveness of therapy

Jump to: navigation, search

Leprosy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Leprosy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Leprosy cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Leprosy cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Leprosy cost-effectiveness of therapy

CDC on Leprosy cost-effectiveness of therapy

Leprosy cost-effectiveness of therapy in the news

Blogs on Leprosy cost-effectiveness of therapy

Directions to Hospitals Treating Leprosy

Risk calculators and risk factors for Leprosy cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

After the results of the campaign of the WHO to eradicate leprosy, the treatment of this disease may be considered cost-effective.

Cost-effectiveness of Therapy

The results of the WHO measures show that with adequate investment in prevention and early treatment of the disease, it is possible to minimize its incidence around the world. Therefore, therapy and research of new and innovative techniques may be considered cost-effective in the case of leprosy.[1]

References

  1. "Leprosy: global situation".

Linked-in.jpg